Atlas Trials

PERCIST Criteria for Response Evaluation With Solid Tumors

Clinical trial NCT02765620 · UNKNOWN

Trial details

NCT number
NCT02765620
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung NeoplasmsBreast NeoplasmsColonic NeoplasmsLymphoma
Start date
2016-04-01
Primary completion
2018-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.